METHODS	Patients received methylprednisonlone and anti-IL2 receptor antagonist ( Basiliximab ) induction and were blindly randomized to either the tacrolimus/mycophenolate mofetil ( n = 45 ) or tacrolimus/sirolimus ( n = 37 ) groups .\